Pharmafile Logo
Pharmafocus logo
Advanced Search

asthma

Showing 7 posts of 82 posts found.

Pfizer drops early-stage asthma candidate

May 11, 2011
Research and Development Pfizer, Rigel, asthma

Pfizer has returned the rights to a phase I asthma candidate to Rigel Pharmaceuticals. San Francisco-based Rigel says Pfizer is …

News

AZ stops making Pulmicort pMDI inhaler

March 8, 2011
Manufacturing and Production AZ, AstraZeneca, Pulmicort, Pulmicort pMDI, Skyepharma, asthma, asthma inhaler, budesonide

AstraZeneca has discontinued production of its Pulmicort pMDI asthma inhaler because of manufacturing issues, and looks set to exit from …

News
GSK’s Seretide/Advair

New COPD and asthma treatments jostle for market space

October 6, 2010
Research and Development, Sales and Marketing COPD, Daxas, Onbrez Breezhaler, Revolair, asthma

Competition in the field of COPD and asthma is hotting up, with new data for several key treatments recently unveiled. …

Feature

Gene-targeting asthma drugs within a decade

September 24, 2010
Research and Development asthma, genetic

Asthma treatments that target genetic variants found in people susceptible to the condition could be available within the next ten …

News

Extra phase II studies boost GSK’s Relovair

September 23, 2010
COPD, GlaxoSmithKline, Relovair, asthma

GlaxoSmithKline has conducted additional phase II trials on its asthma/COPD drug Relovair to answer a number of safety and efficacy …

News

MSD launches asthma training resources

August 6, 2010
Medical Communications, Sales and Marketing MSD, asthma, medical education, merck sharp and dohme, nurses

A new training resource aimed at helping primary care nurses manage asthma has been launched with funding from Merck Sharp …

News

NICE rejects Xolair for children

June 3, 2010
Sales and Marketing NICE, Xolair, asthma

The drug was first approved in Europe in November 2005 for patients aged 12 or older, and gained NICE approval …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026